CD8A and cancer: In addition, the high expression of MGP in cancer cells from both the primary CRC or LM sites increases intracellular Ca2+ to boost NF-κB phosphorylation, which mediates PD-L1 upregulation in CRC cells, thus promoting CD8+ T-cell dysfunction [154].